A Case of Paronychia Occurring after Injection with Cetuximab (Erbitux(R), IMC-C225).
- Author:
Min Kyung SHIN
1
;
Ik Joon KANG
;
Si Young KIM
;
Mu Hyoung LEE
Author Information
1. Department of Dermatology, College of Medicine, Kyung Hee University, Seoul, Korea. mhlee@khmc.or.kr
- Publication Type:Case Report
- Keywords:
Cetuximab;
Paronychia
- MeSH:
Adult;
Anti-Bacterial Agents;
Edema;
Erythema;
Female;
Humans;
Paronychia*;
Receptor, Epidermal Growth Factor;
Rectal Neoplasms;
Cetuximab
- From:Korean Journal of Dermatology
2006;44(8):1007-1009
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
We report a case of paronychia induced by cetuximab in a 43-year-old woman. Cetuximab is an antibody to the epidermal growth factor receptor, and has previously been shown to block the proliferation of various cancer cells. The patient had taken cetuximab for the treatment of metastatic rectal cancer. One month after the injection of cetuximab, the patient visited our clinic with painful periungal edema and erythema. The lesions partially improved after treatment with systemic and topical antibiotics. But, after discontinuing cetuximab, there was a significant decrease in the erythematous and edematous plaques. Three weeks later, she was asymptomatic and the lesions had resolved completely.
